Efficacy and safety of CM310 in moderate-to-severe atopic dermatitis: A multicenter, randomized, double-blind, placebo-controlled phase 2b trial
CM310治疗中重度特应性皮炎的疗效和安全性:一项多中心、随机、双盲、安慰剂对照的2b期试验
期刊:Chinese Medical Journal
影响因子:7.3
doi:10.1097/CM9.0000000000002747
Zhao, Yan; Zhang, Jianzhong; Yang, Bin; Li, Jingyi; Ding, Yangfeng; Wu, Liming; Zhang, Litao; Wang, Jinyan; Zhu, Xiaohong; Zhang, Furen; Tao, Xiaohua; Li, Yumei; Zhang, Chunlei; Li, Linfeng; Lu, Jianyun; Diao, Qingchun; Lu, Qianjin; Man, Xiaoyong; Li, Fuqiu; Xia, Xiujuan; Cheng, Hao; Jia, Yingmin; Zhao, Guoqing; Yan, Jinchun; Chen, Bo